期刊文献+

Podoplanin促进肿瘤侵袭转移的机制及其临床意义 被引量:4

Mechanisms of Tumor Invasion and Metastasis Induced by Podoplanin and Its Clinical Implication
下载PDF
导出
摘要 Podoplanin最早发现于肾小球的足突细胞膜,属于Ⅰ型黏液样跨膜糖蛋白。Podoplanin表达于淋巴管内皮细胞(LEC)和部分正常组织细胞的表面,在促进淋巴管生成、防止细胞粘附和维持肾小球足突细胞形态方面具有重要作用。作为LEC的特异性标记物,许多研究通过检测Podoplanin在LEC上的表达,测量肿瘤内部和周边的微淋巴管密度(LMVD),进而阐明LMVD和肿瘤淋巴结转移、肿瘤预后的相关性。Podoplanin还广泛表达于恶性肿瘤细胞的表面,如大多数的鳞状细胞癌、生殖细胞肿瘤和中枢神经系统肿瘤。Podoplanin可以促使ERM蛋白磷酸化,调整Rho家族成员GTP酶的活性和重组肌动蛋白细胞骨架等,最终引起细胞的侵袭和转移。因此,Podoplanin在判断肿瘤的恶性程度、转移及预后方面具有重要意义,并有望为抗肿瘤治疗提供一条新思路。 Podoplanin, originally found on the surface of podocytes, belongs to the family of type-1 transmembrane sialomucin-like glycoproteins. Podoplanin is expressed on the surface of the lymphatic endothelium cell (LEC) and some normal tissues. It is involved in lymphatic vessel (LV) formation and the regulation of the shape of the podocyte foot and plays an important role in preventing cellular adhesion. As a specific marker of LEC, podoplanin has been used in many studies to detect LEC and to evaluate the LV microvascular density (LVMD) in peritumoral and intratumoral areas. Podoplanin is also expressed on the surface of malignant tumor cells, such as most squamous cell carcinomas, germ cell tumors, and tumors of the central nervous system. Podoplanin can increase the phosphorylation of ERM proteins, modulate the activity of Rho-family GTPases (in particular RhoA) and remodel the actin cytoskeleton, thus can induce tumor invasion and metastasis. Podoplanin is useful in determining the degree of malignancy, metastasis and prognosis, and may provide a new approach for anti-tumor therapy.
作者 张松 邹利光
出处 《中国肿瘤临床》 CAS CSCD 北大核心 2010年第9期536-539,共4页 Chinese Journal of Clinical Oncology
关键词 PODOPLANIN 肿瘤侵袭 肿瘤转移 淋巴管内皮细胞 Podoplanin Tumor invasion Tumor metastasis Lymphatic endothelial cell
  • 相关文献

参考文献20

  • 1Hirakawa S.From tumor lymphangiogenesis to lymphvascular niche[J].Cancer Sci,2009,100(6):983-989.
  • 2Raica M,Cimpean AM,Ribatti D.The role of podoplanin in tumor progression and metastasis[J].2008,28(5B):2997-3006.
  • 3Ji RC.Lymphatic endothelial cells,tumor lymphangiogenesis andmetastasis:new insights into intratumoral and peritumoral lymphatics[J].Cancer Metastasis Rev,2006,25(4):677-694.
  • 4Wicki A,Christofori G.The potential role of podoplanin in tumour invasion[J].Br J Cancer,2007,96(1):1-5.
  • 5Schacht V,Dadras SS,Johnson LA,et al.Up-regulation of the lymphatic marker podoplanin,a mucin-type transmembrane glycoprotein,in human squamous cell carcinomas and germ cell tumors[J].Am J Pathol,2005,166(3):913-921.
  • 6Suzuki-Inoue K,Kato Y,Inoue O,et al.Involvement of the snaketoxin receptor CLEC-2,in podoplanin-mediated platelet activation,by cancer cells[J].J Biol Chem,2007,282(36):25993-26001.
  • 7Wicki A,Lehembre F,Wick N,et al.Tumor invasion in the absence of epithelial-mesenchymal transition:podoplanin-mediatedremodeling of the actin cytoskeleton[J].Cancer Cell,2006,9(4):261-272.
  • 8Martín-Villar E,Megías D,Castel S,et al.Podoplanin binds ERMproteins to activate RhoA and promote epithelial-mesenchymaltransition[J].J Cell Sci,2006,119(Pt 21):4541-4553.
  • 9Cueni LN,Detmar M.Galectin-8 interacts with podoplanin andmodulates lymphatic endothelial cell functions[J].Exp Cell Res,2009,315(10):1715-1723.
  • 10Alitalo K,Tammela T,Petrova TV.Lymphangiogenesis in develop-ment and human disease[J].Nature,2005,438(7070):946-953.

二级参考文献27

共引文献20

同被引文献52

  • 1Li, Lan,Shi, Yong-Hong,Guo, Zhi-Juan,Qiu, Tian,Guo, Lei,Yang, Hong-Ying,Zhang, Xun,Zhao, Xin-Ming,Su, Qin.Clinicopathological features and prognosis assessment of extranodal follicular dendritic cell sarcoma[J].World Journal of Gastroenterology,2010,16(20):2504-2519. 被引量:19
  • 2Cui YL,Wang YN,Hui WL,et al.The synthesis of GoldMag nano-particles and their application for antibody immobilization.Biomed Microdevices,2005,7(2):153-156.
  • 3Sleeman JP,Thiele W.Tumor metastasis and the lymphatic vasculature.Int J Cancer,2009,125(12):2747-2756.
  • 4Wicki A,Christofori G.The potential role of podoplanin in tumour invasion.Br J Cancer,2007,96(1):1-5.
  • 5Yang L,Peng XH,Wang A,et al.Receptor-targeted nanoparticles for in vivo imaging of breast cancer.Clin Cancer Res,2009,15(14):4722-4732.
  • 6Sun C,Lee JSH,Zhang MQ.Magnetic nanoparticles in MR imaging and drug delivery.Adv Drug Deliver Rev,2008,60(11):1252-1265.
  • 7Li XB,Du XK,Huo TL,et al.Specific targeting of breast tumor by octreotide-conjugated ultrasmall superparamagnetic iron oxide particles using a clinical 3.0-tesla magnetic resonance scanner.Acta Radiol,2009,50(6):583-594.
  • 8Chavhan GB,Babyn PS,Thomas B,et al.Principles,techniques,and applications of T2^*-based MR imaging and its special applications.Radiographics,2009,29(5):1433-1449.
  • 9Thorek DLJ,Chen AK,Czupryna J,et al.Superparamagnetic iron oxide nanoparticle probes for molecular imaging.Ann Biomed Eng,2006,34(1):23-38.
  • 10Nguyen VA,Furhapter C,Obexer P,et al.Endothelial cells from cord blood CD133^+ CD34^+ progenitors share phenotypic,functional and gene expression profile similarities with lymphatics.J Cell Mol Med,2009,13(3):522-534.

引证文献4

二级引证文献12

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部